Geraldine Villanueva-Rodríguez

Suggest Changes
Learn More
PURPOSE This randomized phase II trial evaluated whether the combination of cisplatin and paclitaxel (PC) plus all-trans retinoic acid (ATRA) increases response rate (RR) and progression-free(More)
A frequent manifestation of advanced NSCLC is malnutrition, even though there are many studies which relate it with a poor survival, its relation with toxicity has not yet been consistently reported.(More)
Oscar Arrieta (ogar@servidor.unam.mx) Rosa Mayela Michel Ortega (mayela_michel@yahoo.com.mx) Geraldine Villanueva-Rodríguez (geral_vr2@yahoo.com) Maria Guadalupe Serna-Thomé (gpeserna@hotmail.com)(More)
  • 1